X0306
4
2018-11-15
false
0001590877
REGENXBIO Inc.
RGNX
0001652827
Vasista Vittal
C/O REGENXBIO INC.
9600 BLACKWELL ROAD, SUITE 210
ROCKVILLE
MD
20850
false
true
false
false
Chief Financial Officer
Common Stock
2018-11-15
4
S
false
2170.00
58.46
D
135113.00
D
Common Stock
2018-11-15
4
S
false
1900.00
59.06
D
133213.00
D
Common Stock
2018-11-15
4
S
false
588.00
60.40
D
132625.00
D
Common Stock
2018-11-15
4
S
false
2042.00
62.23
D
130583.00
D
Common Stock
2018-11-15
4
S
false
700.00
63.05
D
129883.00
D
Common Stock
2018-11-15
4
S
false
100.00
64.10
D
129783.00
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $57.68 to $58.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $58.81 to $59.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $59.98 to $60.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $61.81 to $62.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $62.81 to $63.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Patrick J. Christmas as attorney-in-fact
2018-11-19